Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma-Reference-Cited by-同舟云学术

Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma

Published:2023-04-25 Issue:1 Volume:38 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Peng Xiaopeng¹²,Yu Ziwen¹²,Surineni Goverdhan¹²,Deng Bulian¹²,Zhang Meizhu¹²,Li Chuan¹²,Sun Zhiqiang¹²,Pan Wanyi¹²,Liu Yao³,Liu Shenglan¹²,Yu Bin⁴,Chen Jianjun¹²

Affiliation:

1. College of Pharmacy, Gannan Medical University, Ganzhou, China

2. School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, China

3. Instrumental Analysis Center, Shanghai Jiao Tong University, Shanghai, China

4. School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China

Funder

National Natural Science Foundation of China

Science and Technology Projects of Ganzhou

Start-Up Foundation of Gannan Medical University

Thousand Youth Talents Program

Organization Department of the CPC Central Committee and International Science and Technology Cooperation Projects of Guangdong Province

Publisher